Cerebral cortical blood flow during loss of consciousness induced by gravitational stress in rhesus monkeys

2001 ◽  
Vol 305 (2) ◽  
pp. 99-102 ◽  
Author(s):  
Geneviève Florence ◽  
Richard Bonnier ◽  
Laurent Riondet ◽  
Didier Plagnes ◽  
Didier Lagarde ◽  
...  
1994 ◽  
Vol 266 (5) ◽  
pp. R1488-R1492
Author(s):  
J. Szmydynger-Chodobska ◽  
A. Chodobski ◽  
C. E. Johanson

Postnatal developmental changes in blood flow to choroid plexuses of the lateral (LVCP) and fourth (4VCP) ventricles and cerebral cortex were studied in pentobarbital-anesthetized rats at 2, 3, 5, and 7-8 wk. Blood flow was measured by indicator fractionation with N-isopropyl-p-[125I]iodoamphetamine as the marker. Blood flow to the LVCP and 4VCP was 2.5 +/- 0.1 and 2.7 +/- 0.1 ml.g-1.min-1, respectively, and did not change between the 2nd and 3rd wk. However, it increased by 34% between the 3rd and 5th wk. From the age of 5 wk on, 4VCP was characterized by higher blood flow rates than LVCP. Cerebral cortical blood flow gradually increased between the 2nd and 5th wk. There was no difference in cortical blood flow between 5-wk-old and adult animals. The changes in choroidal blood flow likely represent a continuing adjustment of the choroidal vascular system to steadily increasing secretory capabilities of the maturing choroidal epithelium.


2019 ◽  
Vol 28 (9-10) ◽  
pp. 1161-1172 ◽  
Author(s):  
Zhaosi Zhang ◽  
Guosheng Zhao ◽  
Liu Liu ◽  
Junchi He ◽  
Rami Darwazeh ◽  
...  

Vascular smooth muscle cells (VSMCs) play an important role after a subarachnoid hemorrhage (SAH). The changes in VSMCs following bexarotene treatment after SAH are unknown. In the present study, neurological impairment, decreased cerebral cortical blood flow and transformation of cerebral VSMCs from a contractile to a synthetic phenotype were observed after SAH. Bexarotene reduced neurological impairment, improved cerebral cortical blood flow, inhibited VSMC phenotypic transformation and suppressed the expression of 5-lipoxygenase-activating protein (FLAP) and leukotriene B4 (LTB4), which was partly reversed by GW9662, an inhibitor of peroxisome proliferator-activated receptor gamma (PPARγ). Mechanistically, sh-PPARγ-mediated phenotypic transformation of VSMCs was partially suppressed by MK886, an antagonist of FLAP. Therefore, we conclude that bexarotene reduced neurological impairment, improved cerebral cortical blood flow and inhibited the VSMC phenotypic transformation after SAH, which was achieved by activating PPARγ-mediated inhibition of FLAP/LTB4 in VSMCs


1984 ◽  
Vol 67 (s9) ◽  
pp. 19P-19P
Author(s):  
J M Allen ◽  
F Schon ◽  
N Todd ◽  
J C Yeats ◽  
H A Crockard ◽  
...  

1988 ◽  
Vol 24 (4) ◽  
pp. 486-489 ◽  
Author(s):  
Marshall Goldstein ◽  
Barbara S Stonestreet ◽  
Benjamin S Brann ◽  
O H William

2004 ◽  
Vol 147 (1) ◽  
pp. 79-84 ◽  
Author(s):  
Ö. Karadağ ◽  
E. Eroğlu ◽  
M. Gürelik ◽  
H. M. Göksel ◽  
E. Kılıç ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document